Strong performance among our North American Holdings, and excellent stock selection within the healthcare, financials, and industrials sectors helped the Allianz RCM Global Small Cap Fund outperform over the quarter. Though stock selection was positive across all other regions, relatively weak performance of our Asian holdings proved a headwind to relative performance. Returns were also held back by stock selection within the materials and energy sectors.
Human Genome Sciences was the top active contributor over the quarter. Shares of the biotech company rose sharply on positive trial results for Benlysta, which the company hopes will be the first drug to receive approval for the treatment of systemic lupus in decades. The company also announced that the U.S. government had placed a second order for the anthrax treatment Raxibacumab, which should generate $151 million in revenue over the next three year
Two web-based financial services oriented companies, Moneysupermarket.com Group and Ebix, Inc., were top contributors over the quarter. Moneysupermarket.com’s announcement of a special dividend was construed by many as a sign that the company’s business had stabilized. MoneySupermarket operates a price comparison website for financial products that was heavily impacted by the steep drop-off in loan and mortgage activity. Meanwhile, online insurance exchange provider Ebix’s “torrid” growth rate helped it make #4 on Fortune’s list of the Fastest Growing Tech Companies and #2 on Fortune’s list of the Best Investments in the World.
Though stock selection in Asia was generally weak, one company from the region, Chinese developer of online games Perfect World Co., Ltd., was a top active contributor over the quarter. Continued strong subscriber and revenue growth helped Perfect World beat expectations, propelling the stock to new highs.
Stock selection among Asian equities hurt, and two Chinese companies made the list of top detractors over the quarter. Asian glass manufacturer Xinyi Glass Holdings Ltd. held back returns as weak demand for auto and construction glass weighed on the company’s earnings. Though it is the second best active performer year to date, shares of China Donxiang Group Co., Ltd finished the quarter flat, making it a top relative detractor over Q3. Going forward, we believe the Chinese sports clothier is well positioned for continued growth as the Chinese consumer market expands.
Finally, enterprise software provider Micro Focus International Plc, challenged investors’ confidence with the unexpected and poorly explained departure of its CEO. The abrupt change caused us to lose conviction in the management team, and we subsequently exited the position.
|